DelSite Files IND for Nasal Powder H5N1 (Bird Flu) Influenza Vaccine
August 20, 2008 12:52 ET
|
DelSite, Inc.
* First Nasal Powder Vaccine Against Bird Flu
* Moving to Clinical Development Stage
* Platform Suitable for Pandemic Preparedness and Epidemic Control
* Significant...
DelSite Biotechnologies Nasal Powder Vaccine Platform Highlighted At Cambridge Healthtech Institute
August 18, 2008 12:37 ET
|
DelSite, Inc.
* Third Annual Immunotherapeutics and Vaccine Summit
* New Approach to Vaccine Delivery
* Significant advantages over Current Vaccine Technologies
* Lead Product Candidate-GelVac(tm) Nasal...
DelSite Reports Second Quarter 2008 Results
August 14, 2008 10:16 ET
|
DelSite, Inc.
Company Fully Focused On Commercial Development
of Vaccine, Drug Delivery and Adjuvant Technologies
Conference Call Scheduled for 4:30 pm Eastern Today
IRVING, Texas,...
DelSite Subsidiary Sabila Industrial in Costa Rica Completes ISO 9001:2000 Inspection
August 04, 2008 12:31 ET
|
DelSite, Inc.
* Sabila Industrial ISO-Certified for More Than Five Years
* No Significant Incidences of Nonconformance Found
* Continued Dedication to Quality
IRVING, Texas, Aug....
DelSite Sells Wound Care Division to Medline Industries
July 31, 2008 10:55 ET
|
DelSite, Inc.
IRVING, Texas, July 31, 2008 (PRIME NEWSWIRE) -- DelSite, Inc. (OTCBB:DSII), a drug and vaccine delivery technology company, today announced it has entered into an agreement to sell its Carrington(r)...
DelSite's New Stock Symbol is DSII.OB
July 31, 2008 07:59 ET
|
DelSite, Inc.
IRVING, Texas, July 31, 2008 (PRIME NEWSWIRE) -- DelSite, Inc. (OTCBB:CARN) (OTCBB:DSII), a drug and vaccine delivery technology company, said its common shares will trade on the OTCBB under the new...
DelSite Advances Nasal Delivery of Therapeutic Peptide
July 15, 2008 10:11 ET
|
DelSite, Inc.
-- GelVac(tm) Nasal Powder Platform Delivers Peptide
Arginine-Vasopressin (AVP) Into Systemic Circulation
-- Peptide Widely Used to Control Urine Output in Patients With
Diabetes...
Carrington Laboratories, Inc. Changes Its Name to DelSite, Inc.
July 08, 2008 08:59 ET
|
DelSite, Inc.
IRVING, Texas, July 8, 2008 (PRIME NEWSWIRE) -- DelSite, Inc. (OTC:CARN) officially became the name of Carrington Laboratories, Inc. on June 30, 2008. The name change was approved by the company's...
DelSite Biotechnologies Announces Master Service Agreement With Accelovance, Inc. for Clinical Services
June 26, 2008 12:44 ET
|
DelSite, Inc.
* First Nasal Powder H5N1 Influenza Vaccine Candidate
* Distinct Advantages for Pandemic Preparedness
* Phase I Dose-Escalating Study
IRVING, Texas, June 26,...
DelSite Announces Development of Unique Synthetic Typhoid Vi Polysaccharide Vaccine Candidate
June 26, 2008 08:59 ET
|
DelSite, Inc.
* Safer and More Economical Approach Against a Major Infectious
Disease That Causes 500,000 to 600,000 Deaths Worldwide Per Year
* Chemical Composition Similar to Marketed Typhoid...